Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Topoi (Dordr) ; 43(2): 337-348, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38757089

RESUMO

If only implicitly, social anthropology has long incorporated joint attention as a research technique employed in what anthropologists call "the field". This paper outlines the crucial role joint attention plays in anthropolgical fieldwork-specifically in Participant Observation-and advances the position that joint attention is a goal rather than a starting point of fieldwork practice. Exploring how anthropologists tentatively use attention as a methodological tool to understand other people's lifeworlds, this paper draws parallels between Participant Observation and ordinary everyday interactions, thus teasing out a view of joint attention as a goal to be reached only by means of knowing what matters to others in the context of the lifeworld they inhabit.

2.
AIDS ; 21(11): 1483-5, 2007 Jul 11.
Artigo em Inglês | MEDLINE | ID: mdl-17589197

RESUMO

To evaluate tenofovir-related nephropathy, we quantified calculated glomerular filtration rates (GFR) and renal tubular function in 46 tenofovir-treated patients and 25 without tenofovir. We also analysed patients who stopped tenofovir for drug-related nephrotoxicity at our clinic. Tenofovir use combined with non-nucleoside reverse transcriptase inhibitors, but not with protease inhibitors, resulted in a significant increase in calculated GFR. Tenofovir use was associated with significantly lower phosphatemia and a marginally increased fractional excretion of uric acid, but no other signs of tubulopathy.


Assuntos
Adenina/análogos & derivados , Infecções por HIV/tratamento farmacológico , HIV-1 , Nefropatias/induzido quimicamente , Organofosfonatos/efeitos adversos , Inibidores da Transcriptase Reversa/efeitos adversos , Adenina/efeitos adversos , Adenina/uso terapêutico , Antirretrovirais/uso terapêutico , Estudos de Casos e Controles , Estudos Transversais , Taxa de Filtração Glomerular , Infecções por HIV/fisiopatologia , Humanos , Nefropatias/virologia , Glomérulos Renais/efeitos dos fármacos , Túbulos Renais/efeitos dos fármacos , Organofosfonatos/uso terapêutico , Inibidores da Transcriptase Reversa/uso terapêutico , Tenofovir
3.
AIDS ; 24(12): 1907-16, 2010 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-20616699

RESUMO

BACKGROUND: Annual syphilis testing was reintroduced in the Swiss HIV Cohort Study (SHCS) in 2004. We prospectively studied occurrence, risk factors, clinical manifestations, diagnostic approaches and treatment of syphilis. METHODS: Over a period of 33 months, participants with positive test results for Treponema pallidum hemagglutination assay were studied using the SHCS database and an additional structured case report form. RESULTS: Of 7244 cohort participants, 909 (12.5%) had positive syphilis serology. Among these, 633 had previously been treated and had no current signs or symptoms of syphilis at time of testing. Of 218 patients with newly detected untreated syphilis, 20% reported genitooral contacts as only risk behavior and 60% were asymptomatic. Newly detected syphilis was more frequent among men who have sex with men (MSM) [adjusted odds ratio (OR) 2.8, P < 0.001], in persons reporting casual sexual partners (adjusted OR 2.8, P < 0.001) and in MSM of younger age (P = 0.05). Only 35% of recommended cerebrospinal fluid (CFS) examinations were performed. Neurosyphilis was diagnosed in four neurologically asymptomatic patients; all of them had a Venereal Disease Research Laboratory (VDRL) titer of 1:>or=32. Ninety-one percent of the patients responded to treatment with at least a four-fold decline in VDRL titer. CONCLUSION: Syphilis remains an important coinfection in the SHCS justifying reintroduction of routine screening. Genitooral contact is a significant way of transmission and young MSM are at high risk for syphilis. Current guidelines to rule out neurosyphilis by CSF analysis are inconsistently followed in clinical practice. Serologic treatment response is above 90% in the era of combination antiretroviral therapy.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Infecções por HIV/complicações , Sífilis/diagnóstico , Treponema pallidum/isolamento & purificação , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Adulto , Feminino , Infecções por HIV/tratamento farmacológico , Infecções por HIV/epidemiologia , Homossexualidade Masculina/estatística & dados numéricos , Humanos , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Risco , Suíça/epidemiologia , Sífilis/tratamento farmacológico , Sífilis/epidemiologia , Estados Unidos/epidemiologia , Sexo sem Proteção
4.
Am J Psychiatry ; 167(2): 143-50, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20008942

RESUMO

OBJECTIVE: High rates of suicide have been described in HIV-infected patients, but it is unclear to what extent the introduction of highly active antiretroviral therapy (HAART) has affected suicide rates. The authors examined time trends and predictors of suicide in the pre-HAART (1988-1995) and HAART (1996-2008) eras in HIV-infected patients and the general population in Switzerland. METHOD: The authors analyzed data from the Swiss HIV Cohort Study and the Swiss National Cohort, a longitudinal study of mortality in the Swiss general population. The authors calculated standardized mortality ratios comparing HIV-infected patients with the general population and used Poisson regression to identify risk factors for suicide. RESULTS: From 1988 to 2008, 15,275 patients were followed in the Swiss HIV Cohort Study for a median duration of 4.7 years. Of these, 150 died by suicide (rate 158.4 per 100,000 person-years). In men, standardized mortality ratios declined from 13.7 (95% CI=11.0-17.0) in the pre-HAART era to 3.5 (95% CI=2.5-4.8) in the late HAART era. In women, ratios declined from 11.6 (95% CI=6.4-20.9) to 5.7 (95% CI=3.2-10.3). In both periods, suicide rates tended to be higher in older patients, in men, in injection drug users, and in patients with advanced clinical stage of HIV illness. An increase in CD4 cell counts was associated with a reduced risk of suicide. CONCLUSIONS: Suicide rates decreased significantly with the introduction of HAART, but they remain above the rate observed in the general population, and risk factors for suicide remain similar. HIV-infected patients remain an important target group for suicide prevention.


Assuntos
Infecções por HIV/psicologia , Suicídio/estatística & dados numéricos , Adulto , Terapia Antirretroviral de Alta Atividade/psicologia , Contagem de Linfócito CD4 , Estudos de Coortes , Feminino , Infecções por HIV/tratamento farmacológico , Humanos , Masculino , Transtornos Mentais/complicações , Transtornos Mentais/psicologia , Distribuição de Poisson , Fatores de Risco , Suicídio/psicologia , Suíça/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA